Tomomitsu Iida
Papers
1
Total Citations
14
H-Index
1
About
Dr. Tomomitsu Iida is a pioneering researcher at the intersection of robotics and regenerative medicine, whose work is redefining the future of cell therapy manufacturing. His primary research areas include robotic automation for cell processing, clinical-grade cell culture systems, and the translation of advanced therapies from bench to bedside. Dr. Iida’s most significant contribution is the development and validation of a robotic cell-processing facility (R-CPF) for clinical research, a breakthrough that addresses one of the field’s greatest challenges: the consistent, scalable, and sterile production of high-quality therapeutic cells. His landmark 2023 paper, which has garnered 14 citations, demonstrates how humanoid robots can reliably automate human cell cultures, moving beyond manual, error-prone processes. This work is not merely technical; it is a foundational step toward making retinal cell therapies—and potentially other cell-based treatments—accessible and reproducible for patients. Dr. Iida’s research stands out for its direct clinical relevance, bridging engineering precision with biological necessity. For any student or researcher exploring the future of automated biomanufacturing, Dr. Iida’s work offers a compelling vision of how robotics can unlock the full potential of regenerative medicine.
Research Focus
Key Achievements
Top Papers
- 1